Laylay, Wenejane C.

HRN: 22-02-57  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/26/2023
CEFUROXIME 500MG (TAB)
01/26/2023
01/26/2023
IV
1.5 G
Loading
For CS For NRFS
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Non-compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: